Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Scott Doak | M | 62 |
Nodus Oncology Ltd.
 Nodus Oncology Ltd. BiotechnologyHealth Technology Nodus Oncology Ltd. develops therapies that target DDR (DNA damage response) to treat cancer. The company is based in Edinburgh, UK. The British company was founded in 2020. The CEO is Ian David Waddell. | - |
| Ian Waddell | M | 61 |
Nodus Oncology Ltd.
Nodus Oncology Ltd. BiotechnologyHealth Technology Nodus Oncology Ltd. develops therapies that target DDR (DNA damage response) to treat cancer. The company is based in Edinburgh, UK. The British company was founded in 2020. The CEO is Ian David Waddell. | - |
| Nicola Broughton | M | - |
Nodus Oncology Ltd.
Nodus Oncology Ltd. BiotechnologyHealth Technology Nodus Oncology Ltd. develops therapies that target DDR (DNA damage response) to treat cancer. The company is based in Edinburgh, UK. The British company was founded in 2020. The CEO is Ian David Waddell. | 2 years |
| Clare Wareing | M | 61 |
Nodus Oncology Ltd.
Nodus Oncology Ltd. BiotechnologyHealth Technology Nodus Oncology Ltd. develops therapies that target DDR (DNA damage response) to treat cancer. The company is based in Edinburgh, UK. The British company was founded in 2020. The CEO is Ian David Waddell. | - |
| Bert Klebl | M | - |
Nodus Oncology Ltd.
Nodus Oncology Ltd. BiotechnologyHealth Technology Nodus Oncology Ltd. develops therapies that target DDR (DNA damage response) to treat cancer. The company is based in Edinburgh, UK. The British company was founded in 2020. The CEO is Ian David Waddell. | - |
| Julia Mary Brown | F | 58 |
Nodus Oncology Ltd.
Nodus Oncology Ltd. BiotechnologyHealth Technology Nodus Oncology Ltd. develops therapies that target DDR (DNA damage response) to treat cancer. The company is based in Edinburgh, UK. The British company was founded in 2020. The CEO is Ian David Waddell. | 2 years |
| Manuelle Debunne | M | - |
Nodus Oncology Ltd.
Nodus Oncology Ltd. BiotechnologyHealth Technology Nodus Oncology Ltd. develops therapies that target DDR (DNA damage response) to treat cancer. The company is based in Edinburgh, UK. The British company was founded in 2020. The CEO is Ian David Waddell. | 2 years |
Connections Chart
Multi-company connection
Statistics
| Country | Connections | % of total |
|---|---|---|
| United Kingdom | 7 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Keith Blundy
- Personal Network
